Reprinted in: Asian Venous Academy Recently, Gleneagles Hospital Hong Kong, a member of the multinational network of IHH Healthcare, together with the Asian Venous Academy and Dr. Smile Medical Group, signed a Strategic Cooperation Agreement on Academic, Clinical, Management, and Medical Innovation in Venous Diseases in Hong Kong. Centered on phlebology, the…
A Systematic Reflection on Methodology, Risk, Downward Standard Shifts, and Future Directions This article is reproduced from the personal blog of Dr. Qiang Zhang and is intended solely for medical education and the sharing of professional information. It does not constitute medical diagnosis or treatment advice, nor can it replace…
December 8, 2025 (United States) The Global CHIVA Program has officially entered the soft-launch phase of its Tier 1 pilot curriculum, releasing two foundational modules—Fundamentals of Ultrasound Knowledge and Device Operation and Fundamentals of Venous Hemodynamics. These modules offer a structured, evidence-based, and internationally standardized learning pathway delivered through a…
Dr. Qiang Zhang 30 years of dedication to innovation and clinical practice in venous management. Today I want to explore a question that may reshape the future of vascular medicine: will phlebology—once considered a subset of vascular surgery—emerge as a fully recognized, standalone specialty with international consensus? This isn’t just speculation.…
Introduction Varicose veins, a prevalent manifestation of chronic venous disease (CVD), are often treated surgically when symptomatic. While traditional approaches involve the removal (stripping) of the great saphenous vein (GSV), the CHIVA (Conservatrice Hémodynamique de l’Insuffisance Veineuse en Ambulatoire) method presents a non-ablative, hemodynamic strategy designed to preserve the venous anatomy while correcting…
Historically, patients undergoing varicose vein treatments have commonly faced prolonged postoperative use of compression stockings, resulting in both inconvenience and psychological burden. Recently, the CHIVA (Conservative Hemodynamic Cure for Venous Insufficiency) method, grounded in precise hemodynamic correction of venous insufficiency, has challenged this conventional approach, significantly reducing reliance on compression…
On APR. 19, 2025, Dr. Smile Vein Center Jinan, part of Dr. Smile Medical Group, hosted THE FIRST CHIVA SALON ON VARICOSE VEINS IN CENTRAL CHINA. The event not only expanded the geographic footprint of the CHIVA Salon Series into China's central regions but also brought renewed momentum to a…
Dr. Qiang Zhang 30 years of dedication to innovation and clinical practice in venous management. New York, NY – May 10, 2025 DR. SMILE MEDICAL GROUP, headquartered in Midtown Manhattan, has officially secured a Health Maintenance Organization (HMO) National Provider Identifier (NPI). This designation marks a significant milestone for the…
Originally contributed by Dr. Qiang Zhang on the Veinsights. While using VaricoSeek—or any AI-powered consultation system—you may occasionally come across an answer that sounds very confident but turns out to be partially incorrect… or even completely made up. In the world of artificial intelligence, this phenomenon has a name: “hallucination.” An…
In a major breakthrough for vascular medicine, Dr. Smile Medical Group has announced the launch of VaricoSeek 1.0, the first AI-powered system dedicated to the diagnosis and management of varicose veins. Developed in collaboration with Tencent’s AI research team, this cutting-edge technology is set to transform clinical workflows and improve…
